Tulavi Therapeutics
Gregory D. Casciaro has over 40 years experience in key leadership roles, in the medical device industry across public and private companies.
In 1995, Mr. Casciaro became The President and Chief Executive Officer (CEO) for General Surgical Innovations. He went on to serve as CEO for a handful of subsequent medtech companies including: Orquest Inc., XTENT, AccessClosure, and most recently Cardiac Dimensions. Greg has since served as a special advisor to the board of directors of Cardiac Dimensions.
Mr. Casciaro has been a member of the board of directors of QT Vascular Ltd. (SGX: QTV), a Singaporean-listed company engaged in the design, assembly and distribution of therapeutic solutions for the minimally invasive treatment of complex vascular diseases, since 2001. He served on the board of directors for Apama Medical Inc., AngioDynamics, Dextera Surgical, and Kerberos Proximal Solutions.
This person is not in the org chart
This person is not in any offices
Tulavi Therapeutics
1 followers
Tulavi is a biomedical company dedicated to making better nerve care more accessible. By engineering simple, elegant solutions to restore nerve balance, Tulavi strives to ensure that caregivers have access to effective, easy-to-use solutions that equip them to proactively prevent nerve pain, promote nerve regeneration and provide a higher standard of patient nerve care.